Pathfinder's Cloar

Now the CEO at Pathfinder Therapeutics is Jim Cloar, who brings a med-devices background. Updated here.

CyberKnife slices into HCA market

Given that Nashville-based Pathfinder Therapeutics' new CEO, Skip Goode (at left), was previously with Sunnyvale-based Accuray Incorporated (Nasdaq: ARAY), a mover in the field of radiosurgery, it is worth noting that Accuray is touting it has just installed its 10th CyberKnife(R) Robotic Radiosurgery System in an HCA facility, in this case Nashville's Sarah Cannon Cancer Center at CentennialMedical Center.

Pathfinder Therapeutics gets CEO, hits the road

Skip Goode now gets to try his hand at capitalizing on the image-guided surgery technology of Vanderbilt University spin-out Pathfinder Therapeutics. Goode brings a long record in medical devices to the challenge. He and other PTI management are telling the story at several venues, this week. Our story's here.